| Trial ID: | L7195 |
| Source ID: | NCT00408577
|
| Associated Drug: |
L-Arginine
|
| Title: |
Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Cardiovascular Disease
|
| Interventions: |
DRUG: L-arginine
|
| Outcome Measures: |
Primary: Evaluation of 6 months L-arginine/placebo oral treatment on glucose tolerance and insulin resistance measured by OGTT | Secondary: Evaluation of 6 months L-arginine/placebo oral treatment on endothelial function
|
| Sponsor/Collaborators: |
Sponsor: IRCCS San Raffaele
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
150
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2004-11
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2006-12-12
|
| Locations: |
Scientific Institute San Raffaele, Milan, 20132, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00408577
|
